Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study ...

A local biotech has not only raised $95 million, but said it plans to bring its first drug into the clinic later this year in ...

The standard treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, a study published Thursday in Blood Neoplasia finds. The treatment can extend survival for about 25% ...

A new art exhibition to raise awareness of rare blood cancers is coming to Bristol. It uses sculptures to represent common ...

A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the ...

a laboratory head in WEHI's Blood Cells and Blood Cancer division, said. "It is these two drugs, working in tandem, that led to the highly effective killing of AML cancer cells in our lab-based ...

The MHH joint project TARGET-MPN is investigating why the disease persists and progresses in malignant bone marrow diseases from the group of myeloproliferative neoplasms despite targeted treatment.

GlycoMimetics CEO Harout Semerjian told investors in March that phase 3 blood cancer results could “fundamentally impact our ...

Patients with a hard-to-treat type of blood cancer are set to be offered pioneering immune drugs as 'standard care' on the NHS. Watchdogs last week gave the green light for pembrolizumab after ...

Derrick Mundweiler is a local father, a registered nurse, a general contractor, and a Hodgkin’s Lymphoma survivor.He’s ...